Members |
targetComponentId |
Broccoli - dietary |
Broccoli (substance) |
diffus neurodermatit |
Atopic dermatitis (disorder) |
Brocq's neurodermatitis |
Atopic dermatitis (disorder) |
traumatisk læsion med knækkede tænder uden komplikation |
Fracture of teeth (disorder) |
traumatisk læsion med knækket tand med komplikation |
Fracture of tooth |
Knækket tand med komplikation |
Fracture of tooth |
Knækket tand uden komplikation |
Fracture of tooth |
bromelinspecifikt ekstrakt |
Product containing bromelains (medicinal product) |
bivirkning af bromhexinhydrochlorid |
Adverse reaction to bromhexine |
bivirkning af bromkomplekser |
Adverse reaction caused by bromine and/or bromine compound (disorder) |
Bromisodrofobi |
A condition where an individual has an intense and irrational fear of body odors, either their own or those of others. This phobia, like other specific phobias, could potentially cause significant distress and might interfere with the individual's daily life and activities. |
Bromocriptine [endocrine use] |
Product containing bromocriptine (medicinal product) |
Bromocriptine [endocrine] |
Product containing bromocriptine (medicinal product) |
Bromocriptine [parkinsons] |
Product containing bromocriptine (medicinal product) |
bromazin + codein 12,5 mg/5 ml/10 mg/5ml syrup |
Bromazine hydrochloride 2.5 mg/mL and codeine phosphate 2 mg/mL oral solution |
brompheniraminmaleat 2 mg + guaifenesin 200 mg + hydrocodonhydrogentartrat 5 mg syrup |
Brompheniramine maleate 400 microgram/mL and guaifenesin 40 mg/mL and hydrocodone bitartrate 1 mg/mL oral solution |
brompheniraminmaleat + pseudoephedrinhydrochlorid 16 mg/240 mg tablet med modificeret udløsning |
Brompheniramine and pseudoephedrine only product in oral dose form |
Brompheniramine maleate + pseudoephedrine hydrochloride 16mg/240mg prolonged-release oral tablet |
Brompheniramine and pseudoephedrine only product in oral dose form |
brompheniraminmaleat 10 mg/ml injektionsvæske, opløsning, ampul |
Product containing precisely brompheniramine maleate 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
brompheniraminmaleat + codeinphosphat + phenylpropanolaminhydrochlorid 2 mg/5 ml 10 mg/5 ml 12,5 mg/5 ml syrup |
Brompheniramine maleate 400 microgram/mL and codeine phosphate 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution |
brompheniraminmaleat + dextromethorphanhydrobromid + phenylpropanolaminhydrochlorid 2 mg/5 ml 10 mg/5 ml 12,5 mg/5 ml syrup |
Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) |
brompheniraminmaleat + dextromethorphanhydrobromid + pseudoephedrinhydrochlorid 2 mg/5 ml 10 mg/5 ml 30 mg/5 ml syrup |
Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and pseudoephedrine hydrochloride 6 mg/mL oral solution |
brompheniraminmaleat + dextromethorphanhydrobromid + pseudoephedrinhydrochlorid 4 mg/5 ml 15 mg/5 ml 45 mg/5 ml syrup |
Product containing precisely brompheniramine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 9 milligram/1 milliliter conventional release oral solution (clinical drug) |
brompheniraminmaleat + dextromethorphanhydrobromid + pseudoephedrinhydrochlorid 4 mg/5 ml 15 mg/5 ml 60 mg/5 ml syrup |
Brompheniramine 800 microgram/mL and dextromethorphan 3 mg/mL and pseudoephedrine 12 mg/mL oral solution |
brompheniraminmaleat 4 mg/5 ml + dextromethorphanhydrobromid 30 mg/5 ml + pseudoephedrinhydrochlorid 60 mg/5 ml syrup |
Brompheniramine 800 microgram/mL and dextromethorphan 6 mg/mL and pseudoephedrine 12 mg/mL oral solution |
Bromsulfalein |
Sulfobromophthalein |
Bromsulphalein clearance |
BSP clearance study |
Bronchioloalveolar adenocarcinoma of lung |
Adenocarcinoma of lung |
Bronkioloalveolært karcinom sygdom |
Adenocarcinoma of lung |
Bronchitis NOS |
Bronchitis |
Bronchitis NOS |
Bronchitis |
Bronchodilator |
Bronchodilator (substance) |
Bronchodilator |
Bronchodilator (substance) |
Bronchopneumonia due to unspecified organism |
Bronchopneumonia (disorder) |
Bronchopneumonia: [unspecified organism] or [chest infection - unspecified] |
Pneumonia |
Bronchoscopy with unlisted bronchoscopic procedure |
Bronchoscopy |
røntgenundersøgelse af bløddele i bronkie |
Plain X-ray of lower respiratory tract (procedure) |
patients bror |
Brother (person) |
Brucella rangiferi tarandi |
Brucella suis biovar 4 |
Brucellosis due to other Brucella sp. |
Brucellosis (disorder) |
Bruise face NOS |
Contusion of face (disorder) |
Bruise face NOS |
Contusion of face (disorder) |
etablering af midlertidig gastrostomi ad modum Brunschwig |
Temporary gastrostomy |
Brush cytology of organ NOC |
Brush biopsy (procedure) |
Brussels sprouts - dietary |
Brussels sprouts (substance) |
Bryophyllum |
Genus Kalanchoe (organism) |
Bryozoan |
Phylum Bryozoa (organism) |
budesonid 0,5 mg/2 ml suspension |
Product containing precisely budesonide 250 microgram/1 milliliter conventional release solution for inhalation (clinical drug) |
budesonid 160 µg + formoterol 4,5 µg tørpulverinhalator |
Budesonide 160 microgram and formoterol fumarate dihydrate 4.5 microgram/actuation powder for inhalation |
budesonid 180 µg, tørpulver til inhalation |
Product containing only budesonide in pulmonary dose form (medicinal product form) |
budesonid 1 mg/2 ml nebulisatorampul |
Product containing precisely budesonide 500 microgram/1 milliliter conventional release solution for inhalation (clinical drug) |
Budesonide 200mcg/spray powder |
Budesonide 200 microgram/actuation powder for inhalation |
budesonid 200 µg inhalationspulver kapsel |
Budesonide 200 microgram/actuation powder for inhalation |
budesonid 200 µg inhalator med spacer-anordning |
Budesonide 200 microgram/actuation solution for inhalation |
budesonid 2 mg/100 ml klysma |
Product containing only budesonide in rectal dose form (medicinal product form) |
budesonid 320 µg + formoterol 9 µg tørpulverinhalator |
Budesonide and formoterol only product in pulmonary dose form |
budesonid 400 µg inhalationspulver kapsel |
Budesonide 400 microgram/actuation powder for inhalation |
budesonid 500 µg/2 ml inhalationsvæske til nebulisator enkeltdosis |
Product containing precisely budesonide 250 microgram/1 milliliter conventional release solution for inhalation (clinical drug) |
budesonid 64 µg vandig næsespray |
Product containing only budesonide in nasal dose form (medicinal product form) |
Budesonide 64mcg conventional release nasal spray |
Product containing only budesonide in nasal dose form (medicinal product form) |
budesonid 80 µg + formoterol 4,5 µg tørpulverinhalator |
Product containing precisely budesonide 80 microgram and formoterol fumarate dihydrate 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) |
budesonid 90 µg, tørpulver til inhalation |
Product containing only budesonide in pulmonary dose form (medicinal product form) |
Budesonide [gastro-intestinal] |
Budesonide (substance) |
budesonid 400 µg + formoterolfumarat-dihydrat 12 µg indåndingsudløst tørpulverinhalator |
Budesonide and formoterol only product in pulmonary dose form |
Budgerigar droppings protein |
Budgerigar droppings |
Bull sheath washing |
Cleaning of prepuce of penis |
Bullera |
Genus Bullera (organism) |
Bullous dermatoses NOS |
Bullous dermatosis |
Bullous dermatoses NOS |
Bullous dermatosis |
Bunyavirus serogroup Bunyamwera |
Bunyamwera virus |
bupivacain 0,105 % infusionsvæske, opløsning, ampul |
Bupivacaine hydrochloride 1.05 mg/mL solution for injection |
Bupivacaine 3.75mg/mL(0.375%) injection solution |
Bupivacaine only product in parenteral dose form |
Bupivacaine hydrochloride + dextrose 7.5mg/82.5mg injection |
Bupivacaine only product in parenteral dose form |
bupivacainhydrochlorid 0,1 % infusionsvæske, opløsning |
Bupivacaine only product in parenteral dose form |
bupivacainhydrochlorid 0,125 % infusionsvæske, opløsning, pose a 250 ml |
Bupivacaine hydrochloride 1.25 mg/mL solution for injection |
bupivacainhydrochlorid + adrenalin 0,5 %/50 µg/10 ml (1:200.000) injektionsvæske, opløsning |
Product containing precisely bupivacaine hydrochloride 5 milligram/1 milliliter and epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Bupivacaine hydrochloride 0.75% injection |
Bupivacaine only product in parenteral dose form |
bupivacainhydrochlorid 0,75 % injektionsvæske, opløsning, ampul |
Bupivacaine only product in parenteral dose form |
bupivacainhydrochlorid 2,5 mg + adrenalinbitartrat 5 µg injektionsvæske, opløsning, hætteglas |
Product containing only bupivacaine and epinephrine (medicinal product) |
bupivacainhydrochlorid 5 mg + adrenalin 5 µg injektionsvæske, opløsning, hætteglas |
Product containing precisely bupivacaine hydrochloride 5 milligram/1 milliliter and epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter conventional release solution for injection (clinical drug) |
bupivacainhydrochlorid 7,5 mg/glucose 82,5 mg injektionsvæske, opløsning, hætteglas |
Bupivacaine only product in parenteral dose form |
bupivacainhydrochlorid + adrenalin 0,75 %/1:200.000 injektionsvæske |
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 7.5 mg/mL solution for injection |
Buprenorphine + naloxone withdrawal |
Buprenorphine and/or naloxone withdrawal |
Buprenorphine 5microgram/hour transdermal patch |
Product containing only buprenorphine in transdermal dose form (medicinal product form) |
Buprenorphine hydrochloride + naloxone hydrochloride |
Product containing buprenorphine and naloxone (medicinal product) |
buprenorphinhydrochlorid 2 mg + naloxonhydrochlorid 0,5 mg sublingval resoriblet |
Buprenorphine 2 mg and naloxone hydrochloride 500 microgram sublingual tablet |
buprenorphinhydrochlorid 8 mg + naloxonhydrochlorid 2 mg sublingval resoriblet |
Buprenorphine (as buprenorphine hydrochloride) 8 mg and naloxone hydrochloride 2 mg sublingual tablet |
bupropionhydrochlorid 100 mg tablet med modificeret udløsning |
Product containing only bupropion in oral dose form (medicinal product form) |
Bupropion hydrochloride 100mg prolonged-release oral tablet |
Product containing only bupropion in oral dose form (medicinal product form) |
bupropionhydrochlorid 200 mg tablet med modificeret udløsning |
Product containing only bupropion in oral dose form (medicinal product form) |
Bupropion hydrochloride 200mg prolonged-release oral tablet |
Product containing only bupropion in oral dose form (medicinal product form) |
bupropionhydrochlorid 300 mg tablet med modificeret udløsning |
Product containing only bupropion in oral dose form (medicinal product form) |
Bupropion hydrochloride 300mg prolonged-release oral tablet |
Product containing only bupropion in oral dose form (medicinal product form) |
bupropionhydrochlorid 50 mg tablet med modificeret udløsning |
Product containing only bupropion in oral dose form (medicinal product form) |
Bupropion hydrochloride 50mg prolonged-release oral tablet |
Product containing only bupropion in oral dose form (medicinal product form) |
Burial occupation NOS |
Burial occupation (occupation) |
Burial occupation NOS |
Burial occupation (occupation) |
Burkholderia |
Genus Burkholderia (organism) |
Burkholderia cocovenenans |
Burkholderia gladioli |
Burkholderia vandii |
Burkholderia plantarii |
Burkitts lymfom i lymfeknuder i aksil og overekstremitet |
Burkitt lymphoma of lymph nodes of upper limb (disorder) |